191 related articles for article (PubMed ID: 25647262)
1. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
[TBL] [Abstract][Full Text] [Related]
3. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
4. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway.
Zhang Z; Chang Y; Zhang J; Lu Y; Zheng L; Hu Y; Zhang F; Li X; Zhang W; Li X
PLoS One; 2017; 12(7):e0179741. PubMed ID: 28678825
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
Wang LK; Xie XN; Song XH; Su T; Chang XL; Xu M; Liang B; Huang DY
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806475. PubMed ID: 30343649
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
7. UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
Lebrun L; Milowich D; Le Mercier M; Allard J; Van Eycke YR; Roumeguere T; Decaestecker C; Salmon I; Rorive S
Oncol Rep; 2018 Nov; 40(5):2497-2506. PubMed ID: 30226613
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
[TBL] [Abstract][Full Text] [Related]
9. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.
Song N; Liu B; Wu JL; Zhang RF; Duan L; He WS; Zhang CM
Tumour Biol; 2013 Oct; 34(5):2599-603. PubMed ID: 23609034
[TBL] [Abstract][Full Text] [Related]
11. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
[TBL] [Abstract][Full Text] [Related]
13. DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
Zhang S; Zhang G; Guo H
Tumour Biol; 2017 Jun; 39(6):1010428317703822. PubMed ID: 28621231
[TBL] [Abstract][Full Text] [Related]
14. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
15. HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway.
Ma H; Qi G; Han F; Gai P; Peng J; Kong B
Cell Commun Signal; 2023 Jun; 21(1):144. PubMed ID: 37328851
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
Tumour Biol; 2016 Apr; 37(4):5165-70. PubMed ID: 26547586
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells.
Guo S; Wang Y; Gao Y; Zhang Y; Chen M; Xu M; Hu L; Jing Y; Jing F; Li C; Wang Q; Zhu Z
Med Sci Monit; 2016 Oct; 22():3951-3960. PubMed ID: 27774979
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.
Fang J; Ge X; Xu W; Xie J; Qin Z; Shi L; Yin W; Bian M; Wang H
J Cell Physiol; 2020 Apr; 235(4):3438-3446. PubMed ID: 31621076
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
20. Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients.
Che X; Yang D; Zong H; Wang J; Li X; Chen F; Chen X; Song X
Urol Oncol; 2012; 30(4):450-6. PubMed ID: 21795072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
